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Gastric adenocarcinoma is one of the leading causes
of cancer mortality worldwide. It arises through a
stepwise process that includes prominent inflamma-
tion with expression of interferon- (IFN-) and mul-
tiple other pro-inflammatory cytokines. We engi-
neered mice expressing IFN- under the control of
the stomach-specific H/K ATPase  promoter to
test the potential role of this cytokine in gastric tu-
morigenesis. Stomachs of H/K-IFN- transgenic mice
exhibited inflammation, expansion of myofibro-
blasts, loss of parietal and chief cells, spasmolytic
polypeptide expressing metaplasia, and dysplasia.
Proliferation was elevated in undifferentiated and
metaplastic epithelial cells in H/K-IFN- transgenic
mice, and there was increased apoptosis. H/K-IFN-
mice had elevated levels of mRNA for IFN- target
genes and the pro-inflammatory cytokines IL-6, IL-1,
and tumor necrosis factor-. Intracellular mediators
of IFN- and IL-6 signaling, pSTAT1 and pSTAT3, re-
spectively, were detected in multiple cell types within
stomach. H/K-IFN- mice developed dysplasia as
early as 3 months of age, and 4 of 39 mice over 1 year
of age developed antral polyps or tumors, including
one adenoma and one adenocarcinoma, which ex-
pressed high levels of nuclear -catenin. Our data
identified IFN- as a pivotal secreted factor that or-
chestrates complex changes in inflammatory, epithe-
lial, and mesenchymal cell populations to drive pre-
2114neoplastic progression in stomach; however,
additional alterations appear to be required for ma-
lignant conversion. (Am J Pathol 2012, 181:2114–2125;
http://dx.doi.org/10.1016/j.ajpath.2012.08.017)
Gastric adenocarcinoma is one of the most common
causes of cancer-related deaths worldwide,1 and al-
though the incidence of these cancers in the United
States is decreasing, the 5-year survival rate is a dis-
mal 27%.2 Gastric cancer in humans develops through
a series of stages, first defined by Correa and Piazuelo,
which includes gastritis, atrophy, intestinal metaplasia,
dysplasia, and carcinoma.3 Infection with Helicobacter
pylori is the greatest single risk factor for the develop-
ment of gastric cancer.4 The gastritis that accompa-
nies Helicobacter infection plays a major role in gastric
cancer development5; however, the key inflammatory
mediators driving this process have not been fully de-
fined. Data from several types of malignancy point to
critical functions for inflammation in cancer,6 with an in-
terplay between extrinsic factors (infection/inflammation)
and intrinsic factors (oncogenes/tumor suppressor
genes) driving neoplastic progression.7 Targeting pivotal
pro-tumorigenic cytokines may thus be useful for the
treatment or prevention of certain types of cancer.8
Interaction of Helicobacter with epithelial cells in the
gastric corpus triggers an immune response that leads to
the production of multiple cytokines and the establish-
ment of chronic inflammation. Polymorphisms in the IL-1
gene predispose to gastric cancer development in hu-
mans,9,10 and overexpression of IL1 in the corpus of
transgenic mice leads to gastric dysplasia and cancer,11
pointing to an important role for this cytokine in gastric
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acterized by elevated expression of interferon- (IFN-),
is activated in Helicobacter-infected stomach and ap-
pears to be required for preneoplastic changes, includ-
ing parietal cell atrophy and the development of gastric
metaplasia known as spasmolytic peptide-expressing
metaplasia (SPEM),12–14 which may be a precursor to
gastric cancer.15
In mice, transgene-driven expression of IFN- in the
brain leads to robust induction of the Hh pathway li-
gand/activator Sonic hedgehog (Shh). This deregu-
lated activation of the Hh signaling pathway in turn
leads to the development of medulloblastoma,16,17 an
Hh pathway–driven brain tumor. Because elevated ac-
tivity of the Hedgehog (Hh) signaling pathway has also
been linked to gastric cancer,18,19 these results raised
the interesting possibility that IFN- may contribute to
inflammation-associated gastric neoplasia in part
through induction of Shh expression and oncogenic
signaling activity.
We tested the potential role of IFN- as a pivotal cyto-
kine driving neoplastic progression in stomach by gen-
erating transgenic mice, designated H/K-IFN-, which
overexpress murine IFN- driven by an H/K ATPase 
promoter, which targets transgene expression to the gas-
tric corpus. We show that IFN- overexpression leads to
inflammation, increased proliferation, parietal cell and
chief cell atrophy, SPEM, an increased number of myofi-
broblasts, dysplasia, and, in a subset of mice, tumor
development. Interestingly, while this work was under-
way, another group produced mice with stomach-tar-
geted overexpression of IFN-. Those mice, in which
IFN- signaling was activated at lower levels than the
mice described here, did not exhibit gastritis and
SPEM. Indeed, these processes, as well as neoplasia
driven by Helicobacter infection or IL-1 overexpres-
sion, were blocked.20 In striking contrast, we show that
robust expression of IFN- in our model is sufficient to
orchestrate multiple changes in inflammatory, epithe-
lial, and mesenchymal cell populations to drive prema-
lignant progression in stomach, though additional al-
terations appear to be required for the development of
full-blown neoplasia.
Materials and Methods
Transgenic Mice and Helicobacter felis
Infection
Mouse IFN- cDNA was amplified from IMAGE clone ID
8733812 using forward primer 5=-CTACCTGACTGGATC-
CTCTGAGACAATGAACGCTAC-3= and reverse primer
5=-GGAGTCGCTGCTGATTCGGATCCTTGACACATC-3=
and subcloned into the BamHI site to replace the Ctox
cDNA in the H/K-Ctox transgene,21 which contains 1059
bp of mouse H/K ATPase  promoter.22 The resulting
H/K-mIFN- transgene was verified by DNA sequencing,
excised from vector with HindIII and SacII, and submitted
to the University of Michigan Transgenic Animal Model
Core for microinjection into F2 embryos from SJL C57BL/6 parents. Eleven H/K-mIFN- founders were pro-
duced, and three exhibited severe SPEM associated with
other histopathological changes. We studied mouse
lines from founders 944 (H/K-IFN-944) and 53 (H/K-
IFN-53), with most data generated from line H/K-IFN-
944. Transgenic mice were backcrossed onto a
C57BL/6J background (The Jackson Laboratory, Bar
Harbor, ME). For Helicobacter felis infections, 2-month-
old C57BL/6J mice were gavaged three times over 3
days with 108 bacteria (CS1 strain), in 100 L of Bru-
cella broth.
Histopathological Scoring
Stomachs were cut along the greater curvature, placed
on filter paper, fixed in 4% buffered paraformaldehyde
overnight at 4°C, cut into strips extending from the fores-
tomach to the proximal duodenum, and transferred to
70% ethanol until processing and paraffin embedding.
Sections (5 m) were stained using hematoxylin and
eosin (H&E) and examined by a board-certified veteri-
nary pathologist (K.A.E.) blinded to the experimental
groups. Scoring was performed to quantify the presence
of inflammation, SPEM, parietal and chief cell atrophy,
gland atrophy, dysplasia, and tumor development. His-
tological scoring was performed on a scale of 0 to 3; 0,
absence of detectable inflammation; 1, multiple focal ar-
eas of inflammation confined to the lamina propria; 2,
inflammation that was widespread and/or that extended
to the submucosa; and 3, transmural infiltration. For
quantification of SPEM, the absence of detectable SPEM
was scored as 0; mild or multifocal SPEM was scored as
1; the presence of SPEM in most fields was scored as 2;
and widespread SPEM in all fields was scored as 3. Loss
(atrophy) of parietal and chief cells was graded as 0, no
loss; loss of cells detected was graded as 1; cell loss
easily identified was graded as 2; and severe loss with
few parietal or chief cells remaining was graded as 3.
Gland atrophy was scored according to the appear-
ance of the glands: 0, no change; 1, small or thin
glands; 2, decreased gland size with space between
glands; and 3, glands widely spaced with many miss-
ing. Dysplasia was scored as positive if there was
cellular atypia with disorganized glands. Elderly H/K-
IFN- mice occasionally developed more advanced le-
sions in their antra. Lesions that were focal but largely
sessile, well differentiated, and had minimal dysplasia
were interpreted as polyps. One focal proliferative lesion
with marked dysplasia was interpreted as an adenoma. A
single lesion with marked dysplasia, cellular atypia, and a
high mitotic index was interpreted as an adenocarci-
noma. For data comparing phenotypes in the corpus and
antrum, inflammation and hyperplasia were scored as
described above, and dysplasia was scored as follows:
0, no gland or cellular atypia; 1, the presence of occa-
sional disorganized glands; 2, the presence of many
disorganized glands; and 3, cellular atypia or expansile
lesion.
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Cytometry
Immunohistochemical analysis was performed as previ-
ously described,23 with minor modifications. Primary an-
tibodies detecting the following antigens were used for
immunostaining: mucin 5AC (#MS-145; NeoMarkers,
Fremont, CA); H/K-ATPase  subunit (#D031-3; Medi-
cal and Biological Laboratories, Nagoya, Japan); in-
trinsic factor (a gift from Dr. David Alpers; Washington
University, St. Louis, MO); Ki-67 (#RM-9106; Thermo
Scientific, Fremont, CA); cleaved caspase 3 (D175,
#9661; Cell Signaling, Danvers, MA); CD45 (#14–
0451; eBioscience, San Diego, CA); CD3 (#A0452; Da-
koCytomation, Glostrup, Denmark); F4/80 (#T-2006;
BMA Biomedicals, Augst, Switzerland); myeloperoxi-
dase (#N1578; DakoCytomation); STAT1 (#ab31369;
Abcam, Cambridge, MA); pSTAT1 (Y701) (#9167; Cell
Signaling); pSTAT3 (Y705) (#9145; Cell Signaling);
-catenin (#C7207; Sigma-Aldrich, St. Louis, MO); TFF2
(anti-spasmolytic polypeptide antibody, #ab49536; Ab-
cam); smooth muscle actin (SMA) (#MS-113-P0; Neo-
Markers); keratin 5 (AF138, #PRB-160P; Covance,
Princeton, NJ); keratin 8 (TROMA-I; DSHB, Iowa City, IA);
and IFN-R (Ifngr2) (N-20, #sc-971; Santa Cruz, Santa
Cruz, CA). Fluorescein-conjugated GSII lectin (Vector
Laboratories, Burlingame, CA) was used to identify
mucous-containing neck cells in normal stomach and
SPEM in H/K-IFN- transgenic mice. The following an-
tibodies were used for immunoblotting: PCNA (#RB-
9055; Thermo Scientific); Shh (#sc-1194; Santa Cruz);
H/K-ATPase  subunit (#D032-3; Medical and Biologi-
cal Laboratories); cleaved Caspase 3 (#9661; Cell Sig-
naling); and GAPDH (#sc-25778; Santa Cruz). Flow
cytometry was performed as previously described,24
with minor modifications. Antibodies for sorting in-
cluded PE rat anti-mouse Ly-6G and Ly-6C (Gr1)
(#561084; BD Biosciences Pharmingen, San Diego,
CA) and PE-Cy7 rat anti-mouse CD11b (#561098; BD
Biosciences Pharmingen).
Immunoblot Analysis
Mucosal scrapings from freshly harvested stomach
were homogenized for 20 minutes on ice by vortexing
every 5 minutes in ice-cold radioimmunoprecipitation
assay (RIPA) lysis buffer containing phosphatase in-
hibitor cocktail and protease inhibitor cocktail, both
from Roche Applied Science (Indianapolis, IN). Ly-
sates were cleared by centrifugation at 12,000  g for
15 minutes at 4°C, aliquoted, and stored at 80°C. A
50-g quantity of protein per lane was separated by
gradient SDS–polyacrylamide gel electrophoresis and
transferred onto a polyvinylidene fluoride membrane.
Immunoblotting and detection were performed as de-
scribed,23 with minor modifications.
RT-qPCR Analysis
Stomach tissue samples were obtained from three to six
independent mice per group, as described in the text,and frozen in RNAlater (Qiagen, Hilden, Germany). Total
RNA was extracted using an RNeasy Mini Kit (Qiagen);
single-stranded complementary DNA was synthesized
using 2 g of total RNA with SuperScript III Reverse
Transcriptase (Invitrogen, Carlsbad, CA), and 2 L of a
1:5 dilution of cDNA was used in a 20-L quantitative
RT-PCR reaction mix containing 2 L of SYBR Green
(1:10,000 dilution; #S-7563; Invitrogen), 100 nmol/L of
each primer, 20 nmol/L fluorescein (#170–8780; Bio-
Rad, Hercules, CA), 0.1 L Platinum Tag polymerase
(#10966–034, Invitrogen), and ultrapure water (#10977; In-
vitrogen). Primer sequences are available upon re-
quest. Real-time quantitation was performed in tripli-
cate for each sample using the iCycler iQ5 Real-Time
PCR System (Bio-Rad) and normalized to glyceralde-
hyde-3-phosphate dehydrogenase. Results are ex-
pressed as relative increase in the level of gene ex-
pression, compared to controls, using the threshold
cycle (Ct) slope method.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism
(version 5) software. Statistical significance was deter-
mined using the two-tailed, unpaired, Student’s t-test.
Data are expressed as mean  SEM. A P value of less
than 0.05 was considered significant. Comparison of
phenotypic scores for inflammation, hyperplasia, and
dysplasia, in the corpus and antrum, was performed us-
ing Spearman’s rank correlation coefficient. For quantifi-
cation of histological changes over time, a Wilcoxon-
Mann-Whitney test (nonparametric) was run with a
multiple comparison P value adjustment.
Results
Production of Stomach-Targeted H/K-IFN-
Transgenic Mice
To determine the consequences of IFN- overexpression
in stomach, we generated transgenic mice using a
1059-bp fragment of the H/K ATPase  subunit pro-
moter22 to target mouse IFN- to gastric parietal and
preparietal cells (Figure 1A). We focused our analysis on
transgenic mouse lines derived from two founders, des-
ignated H/K-IFN-944 and H/K-IFN-53. Gastric corpus
isolated from both lines of mice exhibited elevated ex-
pression of IFN- mRNA, with levels in the H/K-IFN-944
line substantially higher than the H/K-IFN-53 line (Figure
1B). Expression of IFN- target genes Mig (Cxcl9) and
IP10 (Cxcl10) was also elevated (Figure 1C), indicating
that IFN- overexpression elicited the expected transcrip-
tional response. IFN- mRNA in H/K-IFN-944 mice was
maintained at comparably high levels at 7 weeks and 15
months of age, whereas 15-month-old H/K-IFN-53 mice
expressed reduced levels of IFN- relative to 7 weeks,
and this was reflected in reduced expression of IFN-
target genes (Figure 1, B and C).
To estimate whether the level of IFN- signaling in
our mice was in the same range as in the setting of
IIFN- and Gastric Preneoplasia 2117
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genes in stomachs of H. felis–infected mice and H/K-
IFN- mice, relative to controls. Mig mRNA expression
levels, relative to controls, were elevated 63-fold in H.
felis–infected mice, 46-fold in H/K- IFN-944 mice, and
37-fold in H/K- IFN-53 mice (Figure 1D). For the IFN-
target gene IP10, expression levels relative to controls
were elevated 2.6-fold in H. felis–infected mice, 17-fold
in H/K-IFN-944 mice, and 14-fold in H/K-IFN-53 mice
(Figure 1D). Taken together, these data support the
notion that the level of IFN- signaling in H/K-IFN-
transgenic mice, assessed by the expression level of
IFN- target genes, is generally comparable to that
observed in H. felis–infected mice.
Grossly, the stomachs from both lines of mice revealed
a thickened and enlarged corpus region, and more than
50% of transgenic mice also exhibited thickening of the
squamous limiting ridge at the junction of the forestom-
ach and corpus (Figure 2A, arrow; see also Supplemental
Figure S1 at http://ajp.amjpathol.org). Interestingly, 38%
of mice from line 53 also contained areas of ectopic
squamous epithelium within the glandular corpus (Figure
2A, arrowheads; see also Supplemental Figure S1 at
http://ajp.amjpathol.org). This was not detected in control
or H/K-IFN-944 mice. Stomach weights from H/K-IFN-
mice were higher than those from control mice at all time
points examined (Figure 2B), and there was an approxi-
mately twofold increase in mucosal thickness of the corpus
at both 5 and 15months of age (Figure 2C). Overexpression
of IFN- in the corpus of transgenic mice thus leads to
sustained elevation of transcripts encoding IFN- and IFN-
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Parietal Cell Atrophy and Spasmolytic Peptide-
Expressing Metaplasia in H/K-IFN- Transgenic
Mice
Stomachs fromH/K-IFN- transgenic mice revealed regions
with marked histological changes involving multiple gastric
cell types as well as a prominent inflammatory infiltrate.
H/K-IFN-mice contained strikingly fewer parietal cells and
chief cells, which were replaced by cells with abundant,
foamy cytoplasm resembling themorphology of metaplastic
cells comprising SPEM (Figure 3, A and B), a putative pre-
neoplastic lesion both in humans and in mice.15 Histopatho-
logical scoring of stomachs collected from control and H/K-
IFN- mice at different ages quantified the presence of
SPEM, parietal and chief cell atrophy, gland atrophy, and
inflammation (Figure 3C), as described in Materials and
Methods. Each of these histological features was either not
detected or minimal in control mice but markedly altered in
H/K-IFN- mice (Figure 3C).
The foamy cells in stomachs of H/K-IFN- transgenic
mice contained abundant mucin identified by staining with
PAS-Alcian blue (Figure 4, A and B), bound GSII lectin
(Figure 4, C and D), and expressed TFF2 (Figure 4, E and
F), supporting a diagnosis of SPEM. Expression of the mu-
cous pit marker, Muc5ac, was generally reduced (Figure 4,
G and H). Immunostaining for the  subunit of H/K ATPase
(H/K ATPase ) revealed both a striking reduction in the
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AJP December 2012, Vol. 181, No. 6the histopathological scoring (Figure 3C). Similarly, the
number of cells expressing the chief cell marker, intrinsic
factor, was also greatly reduced (Figure 4, K and L). In
contrast, there was a marked expansion of mesenchymal
cell expressing smooth muscle actin (SMA) (Figure 4, M
and N), a marker of myofibroblasts.
IFN- Expression in Stomach Leads to
Increased Proliferation and Cell Death
Additional immunostaining revealed increased prolifera-
tion in the corpus of H/K-IFN- transgenic mice. In con-
trast to control mice, where expression of the proliferation
marker Ki-67 is largely restricted to a narrow band of cells
within the isthmus region of each gastric gland, in H/K-
IFN- mice there was both an increase in the number of
Ki-67–positive cells and a broader distribution, with ex-
pansion deeper into gastric glands and more superfi-
cially (Figure 5, A–D). Co-immunostaining for Ki-67 and
lineage markers revealed that proliferating cells in H/K-
IFN-mice did not express Muc5ac (Figure 5, E and F) or
H/K ATPase  (Figure 5, G and H), but some cells that
bound GSII lectin were also Ki-67 positive (Figure 5, I and
J). Thus, although neither the differentiated mucous pit
nor the parietal cells are induced to proliferate in re-
sponse to stomach-targeted expression of IFN-, a sub-
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Figure 2. IFN- overexpression in stomach results in a sustained increase in
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0.01, ***P  0.001.set of metaplastic cells do express Ki-67.In addition to enhanced proliferative activity, immuno-
staining for cleaved caspase 3 revealed increased apop-
tosis in the corpus of H/K-IFN- transgenic mice, and
occasionally these cells were also positive for H/K AT-
Pase  (Figure 5, K–N), suggesting that the loss of pari-
etal cells is due at least in part to increased cell death.
Immunoblotting studies examining markers of prolifera-
tion, differentiation, and cell death confirmed immuno-
staining results. Mucosal lysates from corpus of H/K-
IFN- transgenic mice contained higher levels of PCNA
and cleaved caspase 3, with reduced levels of the H/K
ATPase  subunit and Sonic hedgehog (Shh) (Figure
5O), both of which are expressed in normal parietal cells,
relative to controls.
We performed immunostaining to localize the expres-
sion pattern of the  subunit of the IFN- receptor, Ifngr2,
in control and H/K-IFN- transgenic mice (see Supple-
mental Figure S2 at http://ajp.amjpathol.org). We co-im-
munostained with fluorescent GSII lectin, as a recent
study reported that Ifngr2 is localized to mucous neck
cells.25 In control mice, Ifngr2 co-localizes with GSII lec-
tin but also stains most cells in the lower portion of the
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AJP December 2012, Vol. 181, No. 6oxyntic glands in the gastric corpus, where chief cells are
localized. In H/K-IFN- transgenic mice, epithelial ex-
pression of Ifngr2 is reduced or absent in regions with
pronounced SPEM, and only a small subset of metaplas-
tic GSII cells express appreciable levels of Ifngr2, in
contrast to GSII mucous neck cells in the control stom-
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with SPEM, it is not possible to ascertain in this setting
whether this is due to chronic stimulation by IFN- with
down-regulation of IFN- receptors, or to loss of some of
the normal cell type(s) that express these receptors. In-
terestingly, scattered Ifngr-expressing cells are detected
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Figure 4. Alterations in gastric cell lineages in
H/K-IFN- mice. A and B: PAS–Alcian Blue stain
reveals massive expansion of mucin-containing
cells, which also bind GS II lection (C and D)
and immunostain with anti-TFF2 (E and F) in
H/K-IFN- mouse corpus. Cells that bind GS II
lectin and express TFF2 in control stomach are
mucous neck cells. (G and H) Cells expressing
the mucous pit cell marker Muc5ac are detected
at reduced levels in H/K-IFN- mice. Parietal
cells, identified by H/K ATPase immunostain-
ing (I and J), and chief cells, immunostained for
intrinsic factor (K and L), are reduced or absent
in H/K-IFN- mice. The number of cells express-
ing the myofibroblast marker SMA (M and N) is
increased in H/K-IFN- mice. Scale bars: 100 m
(A–L); 200 m (M and N).
D
H/K-IFN-
H
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Figure 5. Expansion of proliferative cell com-
partment and increased apoptosis in H/K-IFN-
mice. A–D: Ki-67 immunostaining. Identification
of cycling, Ki-67–expressing cells in control (A
and C) and H/K-IFN- mice (B and D) reveals
marked expansion of the proliferative zone in
H/K-IFN- mice. E–J: Double-immunostaining
for Ki-67 and lineage markers. Proliferating cells
in H/K-IFN-mice do not express the mucous pit
marker Muc5ac (E and F) or parietal cell marker
H/K ATPase (G and H), but a subset of Ki-67–
expressing cells binds GSII lectin (I and J, ar-
rowheads). K–N: Co-immunostaining reveals
that a subset of H/K ATPase-expressing cells in
H/K-IFN- mice also express the apoptosis
marker cleaved caspase 3 (CC3) (N, arrow-
heads). O: Immunoblotting using corpus lysates
shows upregulation of PCNA, reduction of H/K
ATPase and Shh (parietal cell markers), and in-
creased expression of the apoptosis marker CC3
(lower band). Scale bars: 100 m (A and B); 40
m (C–J, K, and M); 20 m (L and N). 
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to be nonepithelial (see Supplemental Figure S2 at http://
ajp.amjpathol.org).
IFN- Overexpression in Stomach Has Biphasic
Effects on Hedgehog Signaling Activity
Although early stages of gastric tumorigenesis are char-
acterized by reduced Shh levels and lowered Hh path-
way activity, likely due largely to the loss of the Shh-
expressing parietal cells, progression to gastric cancer is
associated with elevated levels of Hh ligands and signal-
ing activity.26,27 The reduced level of Shh protein in H/K-
IFN- mice (Figure 5O) was associated with lower Hh
pathway activity in regions with prominent SPEM, de-
tected by x-gal staining of stomachs from 10-week-old
H/K-IFN-;Gli1-lacZ Hh target gene reporter mice (see
Supplemental Figure S3 at http://ajp.amjpathol.org).
Quantitative PCR at 7 weeks of age revealed similar lev-
els of mRNA encoding Shh, Indian hedgehog (Ihh), and
the Hh target genes Gli1 and Hhip in the corpus of H/K-
IFN- and control mice, with the target gene Ptch1 ex-
pressed at lower levels in H/K-IFN-944 mice than in con-
trols (see Supplemental Figure S3 at http://ajp.amjpathol.
org). At 15 months of age, however, statistically signifi-
cant increases were noted in the expression of Shh and
Ihh, as well as Ptch1 and Hhip, in H/K-IFN- transgenic
mice relative to controls (see Supplemental Figure S3 at
http://ajp.amjpathol.org).
Robust Inflammation, Cytokine Induction, and
Activation of STAT1 and STAT3 in H/K-IFN-
Transgenic Mice
Inflammatory cells in H&E-stained sections of H/K-IFN-
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FEmice were distributed in regions throughout the corpus inthe mucosa and occasionally submucosa (Figure 3, A
and B), and contained variable amounts of mononuclear
cells, including plasma cells, and neutrophils (Figure 6, A
and B). Immunostaining to detect CD45 confirmed in-
creased numbers of leukocytes in the corpus of H/K-
IFN- transgenic mice (Figure 6, C and D). The infiltrate
included T lymphocytes (CD3-positive) (Figure 6, E and
F), macrophages (F4/80 antigen-positive) (Figure 6, G
and H), and neutrophils (myeloperoxidase-positive) (Fig-
ure 6, I and J).
The robust inflammation in H/K-IFN- mice was ac-
companied by elevated expression of mRNAs encoding
markers for distinct subsets of T cells and multiple cyto-
kines, measured at both 7 weeks and 15 months of age.
Quantitative PCR revealed upregulation of transcripts en-
coding T helper cell markers T-bet and Foxp3, markers of
Th128 and Treg29 cells, respectively (Figure 7). In addi-
tion, H/K-IFN- mice expressed elevated levels of
transcripts encoding the Th1-related cytokines tumor ne-
crosis factor– (TNF-) and IL-12 (p40); as well as the
Treg-related anti-inflammatory cytokine IL-10 (Figure 7).
Transcripts encoding the pro-inflammatory cytokines
IL-1 and IL-6, both implicated in tumorigenesis in stom-
ach, were also upregulated (Figure 7). IL-11 was signifi-
cantly elevated in H/K-IFN-944 mice, but only at 15
months of age.
H/K-IFN- mice did not express significantly higher
levels of mRNAs encoding the Th17 marker RORT and
Th17 cytokines IL-17A, IL-17B; Th17-related IL-23 (p19);
Th1-related IL-12 (p35); and the Th2 marker Gata3 and
Th2 cytokine IL-4 (see Supplemental Figure S4 at http://
ajp.amjpathol.org). These findings are in keeping with
the inhibitory effects of IFN- on Th2 and Th17 devel-
opment. Overexpression of IFN- in mouse corpus thus
activates a robust, sustained inflammatory response
with a predominant Th1 profile. Interestingly, despite
IFN-
Figure 6. Mixed inflammatory infiltrate in corpus of H/K-
IFN- mice. A and B: Inflammatory infiltrate in corpus of
H/K-IFN- mouse showing mononuclear cells, plasma cells
(arrowhead), and neutrophils (arrow). C andD: Anti-CD45
immunostaining confirms the presence of leukocytes in the
lamina propria (asterisk) and submucosa (arrowhead) of
the gastric corpus of a H/K-IFN- mouse. T cells are identi-
fied by anti-CD3 (E and F), macrophages by anti-F4/80 (G
and H), and neutrophils by anti-myeloperoxidase (I and J)
immunostaining. Scale bars: 30 m (A and B); 100 m (C–J).J
H/K-markedly higher levels of IFN- in H/K-IFN-944 than
ical sign
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AJP December 2012, Vol. 181, No. 6H/K-IFN-53 mice (Figure 1B), upregulation of mRNA
for most of the cytokines examined, including those
previously implicated in gastric metaplasia and trans-
formation (IL-6, TNF-, and IL-1), was generally com-
parable in both lines of H/K-IFN- mice (Figure 7). This
suggests that a threshold sufficient for near-maximal
signaling may have been reached even in the lower-
expressing H/K-IFN-53 mice.
To test the requirement for acquired immunity in the
phenotypic changes detected in H/K-IFN- mice, we
generated mice deficient in B and T cells by breeding
H/K-IFN- mice with mice carrying Rag1 null alleles.30
The histopathological score for H/K-IFN- and H/K-IFN-;
Rag1/mice was not appreciably different (see Supple-
mental Figure S5 at http://ajp.amjpathol.org): epithelial
changes and inflammation were present in both groups
of mice. As expected, immunostaining for CD3 confirmed
the absence of T-cells in Rag1/ and H/K-IFN-;
Rag1/ mice (see Supplemental Figure S5 at http://
ajp.amjpathol.org). These data show that the marked phe-
notypic changes seen in corpus of H/K-IFN- transgenic
mice are not dependent on acquired immunity and reflect
similar findings in H/K ATPase-targeted IL-1-expressing
mice, where T-cell function is dispensable but myeloid-
derived suppressor cells (MDSCs) may play an impor-
tant role in the development of gastritis and dyspla-
sia.11 In light of these findings, we performed flow
cytometry to assess whether IFN- overexpression also
leads to recruitment of MDSCs. As shown in Supple-
mental Figure S6 (available at http://ajp.amjpathol.org),
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Figure 7. Prolonged elevation of pro-inflammatory cytokines in corpus o
measured by quantitative PCR in RNAs isolated from control, H/K-IFN-944, a
expressed elevated levels of Th1 and regulatory T markers and cytokine
6 for H/K-IFN-53 mice. Data are expressed as mean  SEM, with statist
***P  0.001.the proportion of MDSCs in H/K-IFN-944 mouse stom-ach is 29-fold higher than in control mice (1.933%
versus 0.0667%; P  0.0001). There is also a 5.5-fold
increase in MDSCs in H/K-IFN-53 mice (0.3667%),
relative to controls (0.0667%), but this is not statisti-
cally significant (see Supplemental Figure S6 at http://
ajp.amjpathol.org). These results are in keeping with
the concept that infiltrating MDSCs may contribute to
the phenotype that develops in H/K-IFN- transgenic
mice, but additional studies would be needed to rigor-
ously address this possibility.
Given the central role of signal transducers of tran-
scription (STATs) in cellular responsiveness to cytokines,
we examined the expression and phosphorylation/activa-
tion status of STAT1 and STAT3 in stomach of H/K-IFN-
mice. Immunostaining for STAT1, pSTAT1, and pSTAT3
revealed very low expression of these signaling mole-
cules in control stomach. In contrast, there was marked
upregulation of these proteins in affected regions of cor-
pus of H/K-IFN- transgenic mice (Figure 8, A–I). Co-
immunostaining with the epithelial cell-surface marker
-catenin revealed pSTAT1 primarily in epithelial cells,
whereas pSTAT3 was detected both in epithelial and in
nonepithelial cells (Figure 8, J and K). Cells expressing
pSTAT3 included parietal cells, GSII lectin-binding
SPEM cells, and SMA-positive mesenchymal cells (Fig-
ure 8, L–T), indicating that STAT3 signaling is activated
in stromal and multiple epithelia cell populations in
H/K-IFN- mice. Immunostaining results for STAT1 and
STAT3 proteins were corroborated by immunoblotting
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AJP December 2012, Vol. 181, No. 6Preneoplastic Progression and Antral Tumor
Development in H/K-IFN- Transgenic Mice
Because SPEM is considered a preneoplastic process
and H/K-IFN- mice developed prominent and persistent
SPEM, we were interested in assessing whether H/K-
IFN- mice were at increased risk for developing gastric
cancer. In addition to metaplasia and other histological
changes quantified in Figure 3C, H/K-IFN- mice devel-
oped dysplasia, cystic gland dilatation with occasional
herniation into the submucosa, and gastric gland atrophy
(Figure 9, A–F). Dysplasia was common in H/K-IFN-
mice: at 3 to 5 months of age, 46% of H/K-IFN-944 and
50% of H/K-IFN-53 mice exhibited areas of dysplasia; in
mice over 12 months of age, 65% of H/K-IFN-944 and
44% of H/K-IFN-53 mice had regions of dysplasia (Fig-
ure 9F). In contrast, dysplasia was not detected in any of
the control mice at similar ages (Figure 9F). The similar
levels of dysplasia in H/K-IFN-944 and H/K-IFN-53 mice
suggests that even the lower-expressing strain 53 pro-
duces sufficient IFN- to drive this preneoplastic change.
This concept is supported by the comparable expression
levels of IFN- target genes, as well as transcripts en-
coding multiple cytokines, in H/K-IFN-944 and H/K-IFN-
53 mice (Figures 1 and 7).
Four of 39 (10%) H/K-IFN- mice over 1 year of age
developed either polyps or more advanced lesions, and,
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supports results of immunostaining. Scale bars: 100 m (A, B, D, E, G, and H)interestingly, all of these were located in the antrum (Fig-ure 9, G, H, J, and K). One H/K-IFN-944 mouse devel-
oped an antral adenoma at 18 months of age (Figure 9, G
and H); two H/K-IFN-53 mice developed antral polyps,
one at 14 months and another at 21 months of age; and
one H/K-IFN-53 mouse developed an antral adenocar-
cinoma (Figure 9, J and K) at 21 months of age. This
tumor was characterized by marked dysplasia, cellular
atypia, and a high mitotic index. In addition, this tumor
contained cells with -catenin localized prominently
to nuclei (see Supplemental Figure S7 at http://ajp.
amjpathol.org), consistent with activated canonical
Wnt/-catenin signaling, which has previously been
linked to gastric cancer development.31,32 Despite the
appearance of advanced lesions in transgenic but not
control mice, this difference was not statistically signif-
icant (Fisher’s exact test, P  0.32).
The development of antral changes was nonetheless
surprising, as IFN- expression in our mice was targeted
to the gastric corpus. We therefore examined several
parameters to look for any correlation between alterations
in the corpus and the antrum. Interestingly, we found a
moderate correlation for hyperplasia (r  0.45; P 
0.0003) but no correlation for inflammation (r  0.12; P 
0.351) or dysplasia (r  0.09; P  0.474) (see Supple-
mental Figure S8 at http://ajp.amjpathol.org). Additional
studies will be required to gain insight into the mecha-
nism underlying antral hyperplasia in this setting and its
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The results of this study establish that stomach-targeted
overexpression of IFN- orchestrates histological changes
associated with neoplastic progression that involve in-
flammatory, epithelial, and mesenchymal cell popula-
tions. Although IFN--overexpressing mice develop dys-
plasia with high penetrance and occasionally develop
more advanced lesions, only one H/K-IFN- mouse de-
veloped an adenocarcinoma. These data support the
notion that although IFN- plays an important role dur-
ing early stages of gastric tumorigenesis, additional
alterations are required for the development of frank
malignancy.
Our findings contrast with those reported by Tu and
colleagues,20 who generated IFN--expressing mice us-
ing the same H/K ATPase  promoter fragment to drive
transgene expression in the corpus. These investigators
found no induction of inflammation or SPEM in their mice;
rather, Helicobacter and IL-1–driven inflammation and
dysplasia were suppressed in their IFN--overexpressing
mice.20 A likely explanation for the disparate results of
these two studies may lie in the different levels of IFN-
signaling in the two models: the relative increase in IFN-
target gene expression in our mice was an order of mag-
nitude higher than that reported in the earlier study, and
in a similar range as seen in H. felis–infected mice (Figure
1). This was associated with upregulation of mRNAs en-
coding multiple pro-inflammatory cytokines, including IL-
B CA
D
I
E
J K
* *
G H
Control H/K-IFN-
H/K-IFN-
Control1, TNF-, and IL-6, at both 7 weeks and 15 months ofage (Figure 7), none of which were upregulated at 12
months of age in the report by Tu and colleagues.20
We detected SPEM, inflammation, and other pheno-
typic changes in the corpus of H/K-IFN-mice (Figure 3),
with dysplasia evident as early as 3 months of age (Fig-
ure 9). As they aged, H/K-IFN- mice developed dilated
cystic glands that sometimes herniated into the submu-
cosa (Figure 9). In addition to changes in the corpus,
some aged mice (12 months) developed more ad-
vanced lesions in the antrum, including one adenoma,
two polyps, and an adenocarcinoma (Figure 9, G, H, J,
and K). The nuclear -catenin detected in the sole ade-
nocarcinoma that developed in one of our mice (see
Supplemental Figure S7 at http://ajp.amjpathol.org) ar-
gues that canonical Wnt/-catenin signaling synergizes
with IFN-, as it does with other signaling molecules,11,32
to drive development of full-blown gastric cancer. Al-
though the number of advanced lesions that develop in
the antra of H/K-IFN- mice is not statistically increased
over that of controls; their presence contrasts sharply
with the lack of tumor development in the corpus, despite
the presence of long-standing pre-neoplastic changes,
and in some cases severe dysplasia (Figure 9, B–E), in
this region of the stomach.
Quantitative mRNA analysis in our mice shows sus-
tained expression of markers for both Th1 (T-bet) and
Treg (Foxp3) T cell subsets, as well as both pro-inflam-
matory (TNF-, IL-1, and IL-6) and anti-inflammatory
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Figure 9. Neoplastic progression in stomach of H/K-IFN-
mice. A–E: Phenotypic changes in the corpus include meta-
plasia, inflammation, parietal and chief cell atrophy, dyspla-
sia, and glandular disorganization. Progression to dysplasia
(asterisk in C) was common, and cystic dilation, submuco-
sal herniation (asterisks in D), and gland atrophy (E) were
also sometimes detected. F: Dysplasia was detected in 44%
to 65% of mice from both transgenic lines, beginning as early
as 3 months of age. Numerals above bars indicate numbers
of mice scored as positive over the number of mice exam-
ined in each group. Dysplasia was not detected in control
mice. G–K: Antral phenotypes included adenomas (G) with
regions of mild dysplasia (H) or severe dysplasia and a single
adenocarcinoma (J andK). Ages of mice: 20.5 months (A–C);
21 months (D and E); 18 months (G–I); 21 months (J and K).
Scale bars: 100 m (A and B); 20 m (C, H, and K); 200 m
(D, G, I, and J); 40 m (E).(IL-10) cytokines (Figure 7). Despite these findings, nei-
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epithelium to IFN-, at least at early time points, as phe-
notypic scoring was similar in control and Rag1-deficient
H/K-IFN- mice (see Supplemental Figure S5 at http://
ajp.amjpathol.org). The increased proportion of MDSCs in
H/K-IFN- mice (see Supplemental Figure S6 at http://
ajp.amjpathol.org) raises the possibility that this cell pop-
ulation may contribute to preneoplastic changes in H/K-
IFN- mice, as proposed by Wang and colleagues11 in
H/K-IL-1 mice.
Cytokine-mediated activation of the transcription factor
Stat3 is emerging as a key driver of inflammation-asso-
ciated tumorigenesis in several organs,33–35 where it may
be activated in epithelial, stromal, or inflammatory cells.36
The importance of this pathway in stomach cancer is
supported by the rapid appearance of gastric tumors in
mice with a mutant form of the IL-6/IL-11 co-receptor
gp130 (gp130Y757F) leading to STAT3 activation,37 and
the correlation between gp130/STAT3 signaling and
prognosis of human gastric cancer.38 Despite robust
pSTAT3 expression in multiple cell types seen in H/K-
IFN- mice (Figure 8), activation of this key signaling
effector is not sufficient to drive advanced stages of tumor-
igenesis in our model. Although IL-6 is the key cytokine
driving oncogenic STAT3 signaling in pancreatic39 and coli-
tis-associated colon cancer,40 IL-11 appears to be prefer-
entially involved in activating STAT3 signaling in stom-
ach.41,42 IL-6 appears to be more consistently elevated
than IL-11 in H/K-IFN- mice (Figure 7), but further studies
will be needed to define the mechanism of STAT3 activation
and its functional consequences in this model.
H/K-IFN- transgenic mice exhibited abnormalities in-
volving squamous epithelia in stomach. Over 50% of
mice from both transgenic lines developed squamous
hyperplasia of the limiting ridge, whereas 6% or less
developed squamous papillomas (see Supplemental Fig-
ure S1 at http://ajp.amjpathol.org). Most strikingly, 38% of
H/K-IFN-53 mice, but none of the H/K-IFN-944 mice or
controls, exhibited foci of squamous epithelium within the
corpus (Figure 2A, and see Supplemental Figure S1 at
http://ajp.amjpathol.org). Squamous metaplasia in the
human stomach has been described rarely, typically in
association with ulcers and/or inflammation,43,44 and it
may be a precursor lesion for the development of squa-
mous cell carcinoma,45,46 which was not detected in
our mice. The appearance of ectopic squamous foci in
only one of the two H/K-IFN- transgenic lines could
indicate that the specific level of IFN-/inflammation
present in line 53 is required for the development of
this phenotype; but we cannot rule out the possibility
that insertional mutagenesis has altered the function of
a gene involved in epithelial cell fate specifically in the
H/K-IFN-53 transgenic line.
Finally, the initial impetus for this project stemmed from
studies showing that IFN- expression in cerebellum
leads to Shh expression, Hh signaling activity, and the
development of medulloblastoma,16,17 raising the possi-
bility that a similar scenario could lead to oncogenic Hh
signaling and contribute to inflammation-associated gas-
tric cancer. In keeping with this idea, IFN- directly acti-
vates Shh gene expression via STAT binding sites47 andleads to upregulation of Shh in cultured canine parietal
cells.48 However, in relatively young H/K-IFN- mice (7
weeks), at a time when IFN- target genes are highly
up-regulated (Figure 1), we find no evidence of increased
Hh pathway activity (see Supplemental Figure S3 at
http://ajp.amjpathol.org). This argues that the link be-
tween IFN-, elevated Shh expression, and tumorigene-
sis described in brain is likely not applicable to stomach.
Moreover, in contrast to neuronal cells, IFN- appears to
inhibit Hh signaling in white adipose tissue,49 underscor-
ing the divergent responses of different cell types to
IFN-. In contrast to the results at 7 weeks of age, both
lines of H/K-IFN- mice at 15 months expressed substan-
tially higher levels of Hh ligands and Hh target genes than
did age-matched controls (see Supplemental Figure S3
at http://ajp.amjpathol.org). Additional studies will be re-
quired to identify Hh-producing and Hh-responsive cells
in this setting, and to ascertain their potential role in
gastric pathology in aging H/K-IFN- mice.
In summary, we have shown that expression of IFN- in
stomach is sufficient to drive a strong and sustained
response involving inflammatory, mesenchymal, and ep-
ithelial cells with multiple features of pre-neoplasia. These
findings strongly support the notion that inflammation
plays a key role during early stages of gastric tumorigen-
esis but is dependent on additional alterations to drive
cancer development, and suggest that targeting key pro-
inflammatory cytokines may provide a useful approach to
chemoprevention.
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